EGM
Engineers Gate Manager Portfolio holdings
AUM
$8.04B
1-Year Return
12.21%
This Quarter Return
+6.7%
1 Year Return
+12.21%
3 Year Return
+28.21%
5 Year Return
+42.98%
10 Year Return
+180.06%
AUM
$5.12B
AUM Growth
+$690M
(+16%)
Cap. Flow
+$411M
Cap. Flow
% of AUM
8.03%
Top 10 Holdings %
Top 10 Hldgs %
5.52%
Holding
2,488
New
610
Increased
781
Reduced
670
Closed
420
Top Buys
| 1 |
KLA
KLAC
|
+$25.2M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$22.4M |
| 3 |
Elevance Health
ELV
|
+$20.9M |
| 4 |
Humana
HUM
|
+$20.3M |
| 5 |
Roblox
RBLX
|
+$20M |
Top Sells
| 1 |
PayPal
PYPL
|
+$33.9M |
| 2 |
Constellation Energy
CEG
|
+$28.3M |
| 3 |
Northrop Grumman
NOC
|
+$25.9M |
| 4 |
Starbucks
SBUX
|
+$22.2M |
| 5 |
ServiceNow
NOW
|
+$19.1M |
Sector Composition
| 1 | Technology | 20.73% |
| 2 | Industrials | 15.45% |
| 3 | Consumer Discretionary | 14.14% |
| 4 | Healthcare | 12.21% |
| 5 | Financials | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
UROY
1976
Uranium Royalty Corp
UROY
$438M
| $52.1K | ﹤0.01% |
+21,321
| New | +$52.1K |
|
|
MRNS
1977
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $51.9K | ﹤0.01% |
29,482
+8,454
| +40% | +$14.9K |
|
1978
Harvard Bioscience
HBIO
$20M
| $51.6K | ﹤0.01% |
19,197
+1,128
| +6% | +$3.03K |
|
1979
Emerald Holding
EEX
$960M
| $50.6K | ﹤0.01% |
+10,144
| New | +$50.6K |
|
1980
Douglas Elliman
DOUG
$230M
| $50.1K | ﹤0.01% |
27,380
-51,538
| -65% | -$94.3K |
|
1981
ICL Group
ICL
$8.07B
| $49.6K | ﹤0.01% |
+11,662
| New | +$49.6K |
|
1982
Gevo
GEVO
$392M
| $49.4K | ﹤0.01% |
+30,300
| New | +$49.4K |
|
|
DADA
1983
DELISTED
Dada Nexus
DADA
| $48.6K | ﹤0.01% |
+25,588
| New | +$48.6K |
|
1984
Vuzix
VUZI
$176M
| $48.6K | ﹤0.01% |
41,543
-9,138
| -18% | -$10.7K |
|
1985
Fossil Group
FOSL
$159M
| $47.5K | ﹤0.01% |
40,622
-30,984
| -43% | -$36.3K |
|
1986
Editas Medicine
EDIT
$230M
| $47.1K | ﹤0.01% |
13,805
-93,548
| -87% | -$319K |
|
1987
Veritone
VERI
$201M
| $45.2K | ﹤0.01% |
12,579
-873
| -6% | -$3.13K |
|
1988
Aclaris Therapeutics
ACRS
$221M
| $44.6K | ﹤0.01% |
38,794
-21,742
| -36% | -$25K |
|
1989
Allot
ALLT
$397M
| $43K | ﹤0.01% |
14,489
+4,489
| +45% | +$13.3K |
|
|
CRON
1990
Cronos Group
CRON
$969M
| $42.8K | ﹤0.01% |
19,550
-11,365
| -37% | -$24.9K |
|
1991
Expensify
EXFY
$174M
| $40K | ﹤0.01% |
20,433
+2,514
| +14% | +$4.93K |
|
1992
Karyopharm Therapeutics
KPTI
$53.8M
| $40K | ﹤0.01% |
3,209
+1,296
| +68% | +$16.1K |
|
1993
SES AI
SES
$410M
| $39.7K | ﹤0.01% |
+62,028
| New | +$39.7K |
|
1994
Sangamo Therapeutics
SGMO
$160M
| $39.4K | ﹤0.01% |
45,440
-11,115
| -20% | -$9.63K |
|
1995
Repare Therapeutics
RPTX
$75.6M
| $39.2K | ﹤0.01% |
11,389
-3,374
| -23% | -$11.6K |
|
1996
Commercial Vehicle Group
CVGI
$70.3M
| $36.1K | ﹤0.01% |
+11,109
| New | +$36.1K |
|
|
OPTN
1997
DELISTED
OptiNose
OPTN
| $36.1K | ﹤0.01% |
3,590
+2,210
| +160% | +$22.2K |
|
1998
FibroGen
FGEN
$46.5M
| $34K | ﹤0.01% |
3,409
| – | – |
|
1999
Spruce Power Holding Corp
SPRU
$28.7M
| $33.4K | ﹤0.01% |
+11,772
| New | +$33.4K |
|
2000
SelectQuote
SLQT
$339M
| $32.4K | ﹤0.01% |
+14,946
| New | +$32.4K |
|